Novo Nordisk Reports 19% Rise In Q4 Profit, Lifts Forecast

by Benzinga Staff
February 2, 2012 5:55 AM | 21 seconds read | Make a Comment

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

Novo Nordisk A/S (NYSE: NVO) reported a 19% rise in its fourth-quarter profit.Novo Nordisk's quarterly net profit climbed to 4.68 billion kroner ($825 million), from 3.95 billion kroner, in the year-ago period. Its sales surged 12% to 18.12 billion kroner ($3.2 billion) from 16.12 billion. For the year ahead, Novo Nordisk projects sales growth of 7% to 11%.Novo Nordisk shares gained 3.93% to $125.48 in pre-market trading.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsNewsGuidanceEarnings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.